Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential.

Desbois AP, Smith VJ.

Appl Microbiol Biotechnol. 2010 Feb;85(6):1629-42. doi: 10.1007/s00253-009-2355-3. Epub 2009 Dec 3. Review.

PMID:
19956944
2.

Mechanisms of resistance: useful tool to design antibacterial agents for drug - resistant bacteria.

Savjani JK, Gajjar AK, Savjani KT.

Mini Rev Med Chem. 2009 Feb;9(2):194-205. Review.

PMID:
19200024
3.

Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity.

Freiberg C, Brunner NA, Schiffer G, Lampe T, Pohlmann J, Brands M, Raabe M, Häbich D, Ziegelbauer K.

J Biol Chem. 2004 Jun 18;279(25):26066-73. Epub 2004 Apr 2.

4.
5.

How many modes of action should an antibiotic have?

Brötz-Oesterhelt H, Brunner NA.

Curr Opin Pharmacol. 2008 Oct;8(5):564-73. doi: 10.1016/j.coph.2008.06.008. Epub 2008 Jul 30. Review.

PMID:
18621146
6.

[Bacterial type II topoisomerases as targets for antibacterial drugs].

Pietrusiński M, Staczek P.

Postepy Biochem. 2006;52(3):271-82. Review. Polish.

PMID:
17201062
7.

Upflow anaerobic sludge blanket reactor--a review.

Bal AS, Dhagat NN.

Indian J Environ Health. 2001 Apr;43(2):1-82. Review.

PMID:
12397675
8.

Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?

Gilbert P, Allison DG, McBain AJ.

J Appl Microbiol. 2002;92 Suppl:98S-110S. Review.

9.
10.

Beer spoilage bacteria and hop resistance.

Sakamoto K, Konings WN.

Int J Food Microbiol. 2003 Dec 31;89(2-3):105-24. Review.

PMID:
14623377
11.

Tailoring an antibacterial peptide of human lysosomal cathepsin G to enhance its broad-spectrum action against antibiotic-resistant bacterial pathogens.

Shafer WM, Katzif S, Bowers S, Fallon M, Hubalek M, Reed MS, Veprek P, Pohl J.

Curr Pharm Des. 2002;8(9):695-702. Review.

PMID:
11945165
12.

Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?

Gilbert P, Allison DG, McBain AJ.

Symp Ser Soc Appl Microbiol. 2002;(31):98S-110S. Review.

PMID:
12481835
13.

Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor.

Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH.

J Antimicrob Chemother. 2007 Sep;60(3):568-74. Epub 2007 Jul 2.

14.

Synthesis and antibacterial activity of peptide deformylase inhibitors.

Huntington KM, Yi T, Wei Y, Pei D.

Biochemistry. 2000 Apr 18;39(15):4543-51.

PMID:
10758004
15.

Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria.

Nakajima Y, Ishibashi J, Yukuhiro F, Asaoka A, Taylor D, Yamakawa M.

Biochim Biophys Acta. 2003 Dec 5;1624(1-3):125-30.

PMID:
14642822
16.

Mechanisms of bacterial biocide and antibiotic resistance.

Poole K.

Symp Ser Soc Appl Microbiol. 2002;(31):55S-64S. Review.

PMID:
12481829
17.

A fatty acid from the diatom Phaeodactylum tricornutum is antibacterial against diverse bacteria including multi-resistant Staphylococcus aureus (MRSA).

Desbois AP, Mearns-Spragg A, Smith VJ.

Mar Biotechnol (NY). 2009 Jan-Feb;11(1):45-52. doi: 10.1007/s10126-008-9118-5. Epub 2008 Jun 25.

PMID:
18575935
18.
19.

[Antimicrobial mechanisms of action].

Calvo J, Martínez-Martínez L.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):44-52. doi: 10.1016/j.eimc.2008.11.001. Epub 2009 Jan 22. Review. Spanish.

PMID:
19218003
20.
Items per page

Supplemental Content

Write to the Help Desk